Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 May;59(5):999-1005.
doi: 10.1161/HYPERTENSIONAHA.111.189662. Epub 2012 Apr 9.

TASK-3 channel deletion in mice recapitulates low-renin essential hypertension

Affiliations
Comparative Study

TASK-3 channel deletion in mice recapitulates low-renin essential hypertension

Nick A Guagliardo et al. Hypertension. 2012 May.

Erratum in

  • Hypertension. 2012 Jun;59(6):e59

Abstract

Idiopathic primary hyperaldosteronism (IHA) and low-renin essential hypertension (LREH) are common forms of hypertension, characterized by an elevated aldosterone-renin ratio and hypersensitivity to angiotensin II. They are suggested to be 2 states within a disease spectrum that progresses from LREH to IHA as the control of aldosterone production by the renin-angiotensin system is weakened. The mechanism(s) that drives this progression remains unknown. Deletion of Twik-related acid-sensitive K(+) channels (TASK) subunits, TASK-1 and TASK-3, in mice (T1T3KO) produces a model of human IHA. Here, we determine the effect of deleting only TASK-3 (T3KO) on the control of aldosterone production and blood pressure. We find that T3KO mice recapitulate key characteristics of human LREH, salt-sensitive hypertension, mild overproduction of aldosterone, decreased plasma-renin concentration with elevated aldosterone:renin ratio, hypersensitivity to endogenous and exogenous angiotensin II, and failure to suppress aldosterone production with dietary sodium loading. The relative differences in levels of aldosterone output and aldosterone:renin ratio and in autonomy of aldosterone production between T1T3KO and T3KO mice are reminiscent of differences in human hypertensive patients with LREH and IHA. Our studies establish a model of LREH and suggest that loss of TASK channel activity may be one mechanism that advances the syndrome of low renin hypertension.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of TASK-3 deletion on urinary aldosterone, plasma renin concentration (PRC), and blood pressure in congenic mice. A, upper, 24-hr. urinary aldosterone excretion normalized to creatinine (ng/mg, UAldo/creatinine) in T1T3KO (black bars, left; n=12), T3KO (black bars, right; n=31) and WT mice (white bars, n=38) on NS diet (0.32% Na+, 0.8% K+; 7 days on diet). A, lower, PRC (mg Ang I/ml/hr) of same WT and KO mice. B, Ratio of UAldo to PRC calculated per mouse and averaged per genotype. C, 24-hr. SBPs and DBPs of conscious mice: T1T3KO (n=5), T3KO (n=11), WT (n=11) using radio-telemetry. Values represent mean ± SEM; *comparison to WT mice (P<0.05).
Figure 2
Figure 2
Effect of diet on UAldo and PRC. A, 24-hr. UAldo/creatinine (ng/mg) of WT (white circles) and T3KO mice (black circles) on each of four salt diets: HK (n=11 per group), LS (n=20-25), NS (n=31-38), HS (n=25-32). A, inset, Expanded scale to show increase in UAldo/creatinine in T3KO versus WT mice on NS or HS diet. B, PRC (mg AngI/ml/hr) of WT and T3KO mice on salt diets. B, inset PRC after candesartan treatment (10mg/kg/day) on LS, NS, or HS for WT and T3KO mice (LS: n=20-25; NS: n=11; HS: n=11). Values represent mean ± SEM; *comparison to WT mice (P<0.05).
Figure 3
Figure 3
Membrane potential, K+ channels and Cyp11β2 expression in the adrenal ZG. T3KO hyperaldosteronism is not explained by differences in ZG baseline Vm, plasma K+, or TASK-1 expression. A, Baseline Vm (mV) of ZG cells in adrenal slices from WT (white bars, n=16) and T3KO mice (black bars, n=17) determined in current clamp. B, Plasma K+ (mmol/L) in WT (white circles) and T3KO mice (black circles) on salt diets (HK: n=11, NS, LS, HS: n=21-26). *Indicates main effect of genotype (P<0.001). C, D, Expression of mRNA (C,TASK-1, TASK-3) and (D, Kcnj5,) in ZG layer isolated by laser microdissection, from WT (n=6) and T3KO (n=6) adrenal slices, measured by RT-PCR and expressed as fold-initial mRNA (2−dCt) relative to actin mRNA. E, mRNA expression of Cyp11β2 in ZG layer, NS (n=6, *P<0.001) or HS (n=4, *P=0.038). F, Western blot analysis of lysates (20 ug total protein) prepared from mouse adrenals (2 adrenals/lane): NS(n=3); HS(n=5); LS(n=4), detected with anti-aldosterone synthase (Cyp11β2) antibody. Values represent mean ± SEM, *comparison to WT mice (P<0.05).
Figure 4
Figure 4
Changes in aldosterone production evoked by Ang II and candesartan. A, Fold increase in 24hr UAldo/creatinine in WT (white circles) and T3KO mice (black circles) induced by exogenous Ang II delivery (s.c. osmotic mini-pumps: 0 (saline vehicle), 0.04, 0.4, 0.8, 1.2, or 4.0 μg/kg/min; n=4-7 per dose). Changes in aldosterone production evoked by vehicle did not differ from that evoked by 0.04 μg Ang II/kg/min (data not included in the graph). *significant difference in dose-response curves between genotypes (P=0.038); EC50 in T3KO mice was ½ that of WT mice. B, Comparison of Ang II-dependent (left) and independent (right) aldosterone production in WT and T3KO mice on Na+ diets (see Figure 2 for n’s). B, upper left, the Ang II-dependent response defined as difference between the UAldo/creatinine before and during candesartan (C) administration (10mg/kg/day). *indicates main effect of genotype (P=0.002). B, upper right, UAldo/creatinine with candesartan defined as Ang II-independent aldosterone production. B, upper insets, expanded scale to highlight differences between genotypes. Values represent mean ± SEM, *comparison to WT mice (P<0.05).
Figure 5
Figure 5
The effects of AT1R blockade and high Na+ diet on ambulatory blood pressure. A, 24-hr. SBP (solid lines) and DBP (dashed lines) of WT (white circles) and T3KO (black circles) on NS (n=11) and NS with candesartan in drinking water (n=5–6). Candesartan (10mg/kg/day) normalized DBP between WT and T3KO mice, while SBP remained significantly elevated (*P<0.001). B, Increase in 24-hr. SBPs (solid lines) and DBPs (dashed lines) induced by HS (ΔHS-NS; n=4-6 per condition). SBP and DBP in WT mice failed to respond to HS challenge (n=6), whereas T3KO mice showed increase in SBP (*P<0.001, n=4), but not DBP (P=0.077, n=4). Values represent mean ± SEM, *comparison to WT mice (P<0.05).

Similar articles

Cited by

References

    1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF, Jr, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266–3281. - PubMed
    1. Gordon RD, Laragh JH, Funder JW. Low renin hypertensive states: Perspectives, unsolved problems, future research. Trends Endocrinol Metab. 2005;16:108–113. - PubMed
    1. Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf) 2007;67:324–334. - PubMed
    1. Stowasser M, Gordon RD. The aldosterone-renin ratio and primary aldosteronism. Mayo Clin Proc. 2002;77:202–203. - PubMed
    1. Tomaschitz A, Maerz W, Pilz S, Ritz E, Scharnagl H, Renner W, Boehm BO, Fahrleitner-Pammer A, Weihrauch G, Dobnig H. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol. 2010;55:2171–2180. - PubMed

Publication types

MeSH terms